Bone marrow stromal cell antigen 2 is broadly expressed in the different pluripotent states of human pluripotent stem cells and regulates the expression of pluripotency genes and three germ layer markers
- PMID: 39718725
- DOI: 10.1007/s13577-024-01160-0
Bone marrow stromal cell antigen 2 is broadly expressed in the different pluripotent states of human pluripotent stem cells and regulates the expression of pluripotency genes and three germ layer markers
Abstract
Human pluripotent stem cells (hPSCs) have at least three distinct states: naïve pluripotency that represents the cellular states of the pre-implantation epiblast cells, primed pluripotency that represents the cellular states of the post-implantation epiblast cells, and formative pluripotency that represents a developmental continuum between naïve and primed pluripotency. Various cell surface markers have been used to define and analyze primed and naïve hPSCs within heterogeneous populations. However, not much is known about common cell surface markers for the different pluripotent states of hPSCs. To study surface molecules important for maintaining naive pluripotency, in this study, we generated murine monoclonal antibodies (MAbs) specific to naïve hPSCs. Subsequent studies showed that N15-F8, one of the MAbs, bound to both naïve and primed hPSCs. Cell surface biotin labeling and subsequent immunoprecipitation proved that N15-F8 recognized bone marrow stromal antigen 2 (BST2) in a conformation-dependent manner. Quantitative polymerase chain reaction (qPCR) revealed that BST2 expression was decreased during the early stages of differentiation via embryoid body (EB) formation in primed hPSCs. BST2 knockdown in primed hPSCs resulted in reduced expression of pluripotency genes. BST2 knockdown in naïve hPSCs also resulted in reduced expression of pluripotency genes and several naïve and primed pluripotent state-specific genes. BST2 knockdown induced the expression of ectoderm and endoderm markers in primed hPSCs, whereas it suppressed the expression of mesoderm markers. The results suggest that BST2 is broadly expressed in the different pluripotent states of hPSCs and regulates the expression of pluripotency genes and three germ layer markers.
Keywords: BST2; Human pluripotent stem cell; Monoclonal antibody; Naïve pluripotency; Primed pluripotency.
© 2024. The Author(s) under exclusive licence to Japan Human Cell Society.
Conflict of interest statement
Declarations. Conflict of interest: The authors have no conflict of interest. Ethical approval: All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at Sejong University (SJ-20140801E3). Consent to participate: Not applicable. Consent of publish: Not applicable.
Similar articles
-
Role of heat shock protein 60 in primed and naïve states of human pluripotent stem cells.PLoS One. 2022 Jun 9;17(6):e0269547. doi: 10.1371/journal.pone.0269547. eCollection 2022. PLoS One. 2022. PMID: 35679330 Free PMC article.
-
Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs.Cell Stem Cell. 2019 Jul 3;25(1):120-136.e10. doi: 10.1016/j.stem.2019.05.001. Epub 2019 May 30. Cell Stem Cell. 2019. PMID: 31155483 Free PMC article.
-
Derivation of new pluripotent stem cells from human extended pluripotent stem cells with formative features and trophectoderm potential.Cell Prolif. 2023 Nov;56(11):e13480. doi: 10.1111/cpr.13480. Epub 2023 Apr 13. Cell Prolif. 2023. PMID: 37052060 Free PMC article.
-
The many faces of Pluripotency: in vitro adaptations of a continuum of in vivo states.BMC Dev Biol. 2017 Jun 13;17(1):7. doi: 10.1186/s12861-017-0150-4. BMC Dev Biol. 2017. PMID: 28610558 Free PMC article. Review.
-
Epigenetic differences between naïve and primed pluripotent stem cells.Cell Mol Life Sci. 2018 Apr;75(7):1191-1203. doi: 10.1007/s00018-017-2703-x. Epub 2017 Nov 13. Cell Mol Life Sci. 2018. PMID: 29134247 Free PMC article. Review.
References
-
- Kinoshita M, Barber M, Mansfield W, et al. Capture of mouse and human stem cells with features of formative pluripotency. Cell Stem Cell. 2021;28(453–71): e8.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous